The emerging role of IL-15 in NK-cell development

Immunology Today

Volumn 21, Issue 3, 2000, Pages 113-116

  Liu, Chau Ching ^a   Perussia, Bice ^b   Young, John Ding E ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLT3 LIGAND; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 7; PROTEIN P40; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; CELL DIFFERENTIATION; CELL MATURATION; COMBINED IMMUNODEFICIENCY; GENE MUTATION; IMMUNOMODULATION; KNOCKOUT MOUSE; LYMPHOCYTE HOMING; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; STEM CELL; T LYMPHOCYTE;

ANIMALS; CELL DIFFERENTIATION; CYTOKINES; INTERLEUKIN-15; KILLER CELLS, NATURAL; MICE; MICE, KNOCKOUT;

EID: 0033997613     PISSN: 01675699     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5699(99)01581-9     Document Type: Short Survey

References (25)

1. Shinkai Y.et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangment. Cell. 68:1992;855-867.
2. Georgopoulos K.et al. The Ikaros gene is required for the development of all lymphoid lineages. Cell. 94:1994;143-156.
3. Williams N.S.et al. Natural killer cell differentiation: insights from knockout and transgenic mouse models and in vitro systems. Immunol. Rev. 165:1998;47-61.
4. DiSanto J.P.et al. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. Proc. Natl. Acad. Sci. U. S. A. 92:1995;377-381.
5. Noguchi M.et al. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell. 93:1993;147-157.
6. + hematopoietic progenitor cells. Blood. 7:1996;2632-2640.
7. Zamai L.et al. Natural killer (NK) cell-mediated cytotoxicity: Differential use of TRAIL and Fas ligand by immature and mature primary human NK cells. J. Exp. Med. 188:1998;2375-2380.
8. Ye W.et al. The involvement of interleukin (IL)-15 in regulating the differentiation of granulated metrial gland cells in mouse pregnant uterus. J. Exp. Med. 184:1996;2405-2410.
9. Allen M.P.et al. Granzymes D, E, F, and G are regulated through pregnancy and by IL-2 and IL-15 in granulated metrial gland cells. J. Immunol. 161:1998;2772-2779.
10. Giri J.G.et al. Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor. EMBO J. 14:1995;3654-3663.
11. Grabstein K.H.et al. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science. 264:1994;965-968.
12. Suzuki H.et al. Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor beta chain. J. Exp. Med. 185:1997;499-505.
13. Lodolce J.P.et al. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity. 9:1998;669-676.
14. Ogasawara K.et al. Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature. 391:1998;700-702.
15. - cells from multipotential murine bone marrow progenitors in a stroma-free culture: definition of cytokine requirements and developmental intermediates. J. Exp. Med. 186:1997;1609-1614.
16. Shaw S.G.et al. Expansion of functional NK cells in multiple tissue compartments of mice treated with Flt3 ligand: implications for anti-cancer and anti-viral therapy. J. Immunol. 161:1998;2817-2824.
17. +) human natural killer cell progenitor that responds to interleukin-15. Blood. 92:1998;3647-3657.
18. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:1995;251-276.
19. Okamura H.et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature. 378:1995;88-91.
20. Magram J.et al. IL-12-deficient mice are defective in IFN-gamma production and type 1 cytokine responses. Immunity. 4:1996;471-481.
21. Takeda K.et al. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity. 8:1998;383-390.
22. - functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12. J. Exp. Med. 184:1996;1845-1856.
23. Kundig T.M.et al. Immune responses in IL-2-deficient mice. Science. 262:1993;1059-1061.
24. - mice. J. Immunol. 157:1996;2366-2373.
25. + T cells, but not natural killer cells. J. Exp. Med. 184:1996;289-293.